Invention Grant
US09255252B2 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
有权
用于拉克罗斯病毒和其他布尼病病毒的减毒病毒疫苗
- Patent Title: Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
- Patent Title (中): 用于拉克罗斯病毒和其他布尼病病毒的减毒病毒疫苗
-
Application No.: US13633633Application Date: 2012-10-02
-
Publication No.: US09255252B2Publication Date: 2016-02-09
- Inventor: Stephen S. Whitehead , Richard S. Bennett , Brian R. Murphy
- Applicant: Stephen S. Whitehead , Richard S. Bennett , Brian R. Murphy
- Agency: Locke Lord LLP
- Agent Bryan D. Zerhusen; Gabriel J. McCool
- Main IPC: C12N7/00
- IPC: C12N7/00 ; A61K39/12 ; C07K14/005 ; C12Q1/70 ; A61K39/00
Abstract:
The invention relates to vaccine compositions including CEV serogroup immunogens, attenuated and inactivated viruses of the CEV serogroup and chimeric Bunyaviridae. Also disclosed are methods of treating or preventing CEV serogroup infection in a mammalian host, methods of producing a subunit vaccine composition or an immunogenic composition, isolated polynucleotides comprising a nucleotide sequence encoding a CEV serogroup immunogen, methods for detecting La Crosse virus (LACV) infection in a biological sample and infectious chimeric Bunyaviridae.
Public/Granted literature
- US20140023679A1 LIVE ATTENUATED VIRUS VACCINES FOR LA CROSSE VIRUS AND OTHER BUNYAVIRIDAE Public/Granted day:2014-01-23
Information query
